TA(E)C-GP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TA(E)C-GP, covering 2024-01-25 to 2024-01-25. Get the full timeline:
Most recent: Clinical Trial Update: TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature [Phase 2, Phase 3]